Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ADVR: BULLS AND BEARS! -- Ignore unavailable to you. Want to Upgrade?

To: JMood who wrote (6022)	5/15/1998 4:49:00 PM
From: frick	Read Replies (1) \| Respond to of 8902

J Mood - I do not think ADVR has approval any where in this world. Several years ago a couple people where dividing up the world for distributorships, but have not heard a thing, probably like good ol ADVR ka put. Reticulose has been around for years and years, seems like if it was a cure for something, it would be out, but that is just my opinion..... I am just waiting for this stock to get hyped then I will bail out, hopefully soon..... Fricks Opinions Only....

To: JMood who wrote (6022)	5/17/1998 10:26:00 AM
From: OLD JAKE JUSTUS	Respond to of 8902

JMood, Frick has given you the correct answer, if you are speaking of approval of Reticulose for COMMERCIAL SALES. There is not, at this moment, anywhere in the world that Reticulcose is approved for COMMERCIAL SALES. Not yet, anyway. But, that may change very soon! Reticulose is being distributed for experimental purposes only. No commercial sales has ever taken place anywhere in the world using Reticulose. As you may know, Reticulose has been approved for Phase 3 testing in Argentina. HPV, or Human Papaloma Virus is one of the maladies being tested. The other, under this study, is HIV. This is the final phase of testing before approval is made by Argentina's equal, of our FDA, the ANMAT. When this is accomplished this MAY, not WILL, open the door for Commercial Sales in Argentina. Once COMMERCIAL SALES, WHEN AND IF, begin, in Argentina, then this MAY, not WILL, open the doors to the other MERCOSUR STATES, for COMMERCIAL SALES, of Reticulose. ADVR must first receive a "Free Sales Certificate" from Argentina, or some developed or developing country to legally begin Commercial Sales of Reticulose, anywhere in the WORLD. I believe that a manufacturing facility will be put into operation in Argentina. Of course, it could already be operational. In my personal opinion, this is an absolute necessity! Everything must fall into place for ADVR and Reticulose for the possibility of successfully establishing Commercial Sales, in Argentina and elsewhere in the world. In my opinion, there are risks involved and there is nothing, that I am aware of, that is carved in stone. ADVR COULD, I did not say WILL, but, COULD suffer many set-backs along the route to world trade, in Reticulose. These are my misguided contentions and opinions. You are entitled to yours. Many thanks, JAKE, the MISGUIDED